MariMed (OTCMKTS:MRMD) and Biostage (OTCMKTS:BSTG) Financial Contrast

MariMed (OTCMKTS:MRMD) and Biostage (OTCMKTS:BSTG) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk.

Profitability

This table compares MariMed and Biostage’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MariMed	-7.82%	-5.00%	-1.29%
Biostage	N/A	N/A	-174.43%

Analyst Ratings

This is a summary of recent ratings and price targets for MariMed and Biostage, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MariMed	0	2	0	0	2.00
Biostage	0	0	1	0	3.00

Institutional & Insider Ownership

0.2% of MariMed shares are owned by institutional investors. 17.3% of MariMed shares are owned by company insiders. Comparatively, 15.3% of Biostage shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

MariMed has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Biostage has a beta of -1.02, suggesting that its stock price is 202% less volatile than the S&P 500.

Valuation & Earnings

This table compares MariMed and Biostage”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MariMed	$159.83 million	0.16	-$14.48 million	($0.03)	-2.11
Biostage	N/A	N/A	-$6.07 million	($0.58)	-7.67

Biostage has lower revenue, but higher earnings than MariMed. Biostage is trading at a lower price-to-earnings ratio than MariMed, indicating that it is currently the more affordable of the two stocks.

Summary

MariMed beats Biostage on 7 of the 12 factors compared between the two stocks.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

About Biostage

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.